What meeting? An annual meeting is called to inform shareholders and approve business. WILSON/TPIV had nothing to report as usual but TPIV had business to approve, BOD member selection and compensation. Go ahead buy all you want today, do not be late to this nightmare. Tomorrow will have no real progress or data to report. As has been reported by TPIV previously, TPIV has no control over MAYO published reports so no MAYO. AZN is dead in the water for now and TPIV can't execute so nothing real to be reported on their trials. Look for the words "real soon", "we are close", "we are changing approach which will be better" "making good progress", "more work possible", "great opportunities but do not have enough bandwidth". Finally, if TPIV is withholding information to make a big splash tomorrow lawsuits will appear, you can not withhold material information from shareholders, it must be reported in a timely manner. So nothing tomorrow, there is no money to be made here and after tomorrow shares will be on the sell side for some time. Get a new CEO, the guy is worthless. And while you are doing that get a few new directors. Remember, MAYO Phase 1 long term results, not statistically significant, will need to do more work to validate this trial, AZN dead in the water for now and getting their butt kicked by others, and TPIV can't execute, so not short term catalyst. If Wilson would have executed in a timely manner over the years we would be position well now but we are very late to party here, changes needed!
News 
Market Data 
Discover 
AI
